GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi SA (LTS:0O59) » Definitions » Allowance For Loans And Lease Losses

Sanofi (LTS:0O59) Allowance For Loans And Lease Losses


View and export this data going back to 2001. Start your Free Trial

What is Sanofi Allowance For Loans And Lease Losses?

Allowance For Loans And Lease Losses only applies to banks.


Sanofi Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi SA (LTS:0O59) » Definitions » Allowance For Loans And Lease Losses
Address
46, avenue de la Great Army, Paris, FRA, 75017
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.